RxDoctor Payments Data

Wendy Tzou, MD

Clinical Cardiac Electrophysiology · Aurora, CONPI 1952493843

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (41.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Abbott at 35.3% of the total. Among clinical cardiac electrophysiology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$349,696in general payments, 2019–2025

Across 660 payments — averaging $529.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$123K
  • Boston Scientific$58K
  • Biosense Webster, Inc.$50K
  • Medical Device Business Services, Inc.$49K
  • Medtronic$48K
  • Biotronik Inc.$7K
  • plus $14K from 6 others
$188,038in research payments, 2019–2025

Across 61 payments — averaging $3082.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$99K
  • Biosense Webster, Inc.$26K
  • Medical Device Business Services, Inc.$24K
  • Boston Scientific$21K
  • Haemonetics Corporation$14K
  • Medtronic$3K

What the payments were for

  • Consulting fees$141,04340%
  • Speaking & faculty fees$146,67242%
  • Travel & lodging$35,29910%
  • Food & beverage$26,6828%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$349,696 in reported general payments places this provider in the 95th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

See all clinical cardiac electrophysiology providers in Colorado

Medicare billing

Part B allowed, 2024
$140,670
Medicare patients
798
Services billed
1,930

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban86$124,785
XareltoRivaroxaban26$43,045
MultaqDronedarone Hcl11$14,042
Dofetilide39$9,950
Flecainide Acetate33$1,642
Metoprolol Succinate55$649
Amiodarone Hcl34$611
SotalolSotalol Hcl19$329
Metoprolol Tartrate38$205
Losartan Potassium18$158
Atorvastatin Calcium21$128
Carvedilol29$73
Furosemide14$66
Lisinopril14$56

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →